Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer
Clinical trial NCT04409288 · TERMINATED
Trial details
- NCT number
- NCT04409288
- Sponsor
- Chinese University of Hong Kong
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2023-10-16
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.